Detalles de la búsqueda
1.
Insights into the Use of Peripherally Acting µ-Opioid Receptor Antagonists (PAMORAs) in Oncologic Patients: from Scientific Evidence to Real Clinical Practice.
Curr Treat Options Oncol
; 22(3): 26, 2021 02 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33635493
2.
Is there a preferred platinum and fluoropyrimidine regimen for advanced HER2-negative esophagogastric adenocarcinoma? Insights from 1293 patients in AGAMENON-SEOM registry.
Clin Transl Oncol
; 26(7): 1674-1686, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38361134
3.
The S-REAL study: Spanish real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy.
Clin Transl Oncol
; 26(7): 1779-1789, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38512450
4.
One-year efficacy and safety of naloxegol on symptoms and quality of life related to opioid-induced constipation in patients with cancer: KYONAL study.
BMJ Support Palliat Care
; 13(e2): e318-e326, 2023 Dec 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33707299
5.
The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapy.
Ther Adv Med Oncol
; 15: 17588359231157641, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36895850
6.
Efficacy of naloxegol on symptoms and quality of life related to opioid-induced constipation in patients with cancer: a 3-month follow-up analysis.
BMJ Support Palliat Care
; 11(1): 25-31, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32376758
Resultados
1 -
6
de 6
1
Próxima >
>>